Bloomberg Anywhere Remote Login Bloomberg Terminal Demo Request


Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.


Financial Products

Enterprise Products


Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000


Industry Products

Media Services

Follow Us

J&J Recalls Some Children’s Tylenol in South Korea

Johnson & Johnson said its South Korea unit recalled some children’s Tylenol after discovering that bottles contained too much of the medicine.

The company withdrew Children’s Dye-Free Tylenol Suspension -- Cherry Flavor in 100 milligram and 500 milligram bottles, said Samantha Lucas, a spokeswoman for New Brunswick, New Jersey-based J&J. Some bottles were found during quality-control tests to have too much acetaminophen, the active ingredient in the drug, she said.

J&J, the world’s biggest maker of health-care products, has faced production issues since 2010, including a U.S. recall of over-the-counter medicines such as children’s Tylenol. As a result, the company closed a factory and signed a consent decree with U.S. regulators to oversee some manufacturing. A variety of other products, including blood-sugar meters, metal hip implants and a bone putty used to stop bleeding, also have been recalled.

The recall in South Korea was announced April 23, Lucas said.

Please upgrade your Browser

Your browser is out-of-date. Please download one of these excellent browsers:

Chrome, Firefox, Safari, Opera or Internet Explorer.